Study panning anti-malaria drug Trump took against COVID faces new questions
Reuters India -

British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

Read this story at , ,


Related Articles